{
    "nctId": "NCT01840293",
    "briefTitle": "Breast Cancer Proteomics and Molecular Heterogeneity",
    "officialTitle": "Breast Cancer Proteomics and Molecular Heterogeneity",
    "overallStatus": "RECRUITING",
    "conditions": "Primary Breast Cancer, Recurrent/Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1780,
    "primaryOutcomeMeasure": "Investigation of proteins and their pathways in primary breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients diagnosed with primary breast cancer attending hospital for the resection of their tumour tissue\n\n   Or\n\n   -Patients with suspected or confirmed recurrent or metastatic breast cancer (Patient has a history of a biopsy- or surgically- (i.e. pathologically) confirmed primary breast cancer) attending hospital for the resection/biopsy and/or treatment of tumour tissue\n\n   Or\n\n   -Patient with suspected (but not necessarily biopsy confirmed) newly diagnosed stage 4 breast cancer attending hospital for the resection/biopsy and/or treatment of their tumour tissue\n2. Patients receiving neoadjuvant treatment are also eligible (if applicable)\n3. Patients have to be \u2265 18 years of age\n4. Patients must be able to give informed consent",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}